VAXIL BIO LTD (VXL.CA) Stock Income Statement
TSX-V:VXL - TSX Venture Exchange - CA92243L1076 - Common Stock - Currency: CAD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 196.00K | 259.00K | 584.00K | 986.00K | 1.35M | |||
| Research and Development | 12.00K | 114.00K | 343.00K | 533.00K | 566.00K | |||
| Selling, General, and Administrative Expenses | 184.00K | 145.00K | 239.00K | 428.00K | 724.00K | |||
| Operating Income | -196.00K | -259.00K | -584.00K | -986.00K | -1.35M | |||
| Interest Income/Expense | 18.00K | N/A | N/A | 0.00 | -11.00K | |||
| Non Recurring Items | N/A | 5.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -178.00K | -254.00K | -584.00K | -986.00K | -1.36M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -178.00K | -254.00K | -584.00K | -986.00K | -1.36M | |||
| EBITDA | N/A | N/A | -582.00K | -961.00K | -1.29M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.07 | -0.09 | -0.21 | -0.01 | -0.01 | |||
| Statistics | ||||||||
All data in CAD